While checking our laboratory developed FISH probes for IRF4 split assay on paraffin sections, we incidentally found IRF4 rearrangement in case 1 (the sample at recurrence; Figure   1A ). The original pathological diagnosis was low-grade B-cell lymphoma, unclassified. The cytogenetic analysis record indicated that this tumor harbored a balanced translocation between the IGK and IRF4 genes, t(2;6)(p11.2;p25). We then performed fusion FISH assays and confirmed IRF4-IGK present and IRF4-IGH absent ( Figure 1B-E) . The primary lesion (biopsied 8 years prior to the index sample) also displayed IRF4 rearrangement. A case that had been diagnosed as low-grade B-cell lymphoma, unclassified in the original institute was presented in a regional pathology conference, 10 days after the identification of case 1. The cytomorphological feature of the case was reminiscent of that of case 1 although paraimmunoblasts were more predominant ( Figure 1P ). The morphology prompted us to perform FISH assays for IRF4, obtaining positive results ( Figure 1L -O). We listed it as case 2. Lymphoma samples (784 cases including 232 low-grade B-cell lymphomas) were screened by split FISH assay for IRF4. Case 3 was identified in this process, and the original pathology diagnosis was low-grade B-cell lymphoma, unclassified. The cytogenetic analysis record, t(2;6)(p12;p25), supported the presence of IRF4-IGK. Cases 1 was also in this cohort, and therefore 2 of 232 low-grade B-cell lymphomas (0.86%) harbored IRF4 rearrangement in the cohort.
Histologically, the infiltrate was basically diffuse, and the lymph node architecture was totally effaced. In case 2, however, broad fibrotic bands divided the lymphoma infiltrate into nodules ( Figure 1K 
